COMP <GO>
APUS vs XBIO // PIOTROSKI F-SCORE QUALITY
Apimeds Pharmaceuticals US Inc. (NYSE) VS. Xenetic Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: APUS 1
— XBIO 3
▲ PIOTROSKI F-SCORE QUALITY LEADER: XBIO
LAST: $3.21 (+4.56%) • MKT CAP: $5.0M
piotroski-score
1/9
LAST: $2.12 (+0.95%) • MKT CAP: $5.0M
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (APUS VS. XBIO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | APUS | XBIO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -6.20% | -30.30% | +24.10 | APUS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 19.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 1/9 | 4/9 | -3.00 | XBIO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.4 | 43.5 | -1.11 | XBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.0M | $5.0M | -$15.7K | XBIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | APUS REV | XBIO REV | APUS GROSS % | XBIO GROSS % | APUS FCF | XBIO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $3.0M | — | — | -$9.0M | -$2.3M |
| FY 2024 | $0 | $2.5M | — | — | -$733.5K | -$2.8M |
| FY 2023 | $0 | $2.5M | — | — | -$627.8K | -$4.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
APUS // BETA —
XBIO // BETA —